STRIDES PHARMA, INC

Roxicodone, a brand of oxycodone, has FDA-approved generic versions available in various strengths (5MG, 15MG, 30MG) from multiple manufacturers. No generic exists for its extended-release form. Beware of counterfeit generics from fraudulent online pharmacies.

Strides Pharma Science's subsidiary, Strides Pharma Global Pte., Singapore, received FDA approval for fluoxetine tabs 60 mg, bioequivalent to TWi Pharmaceuticals' RLD. This addition completes the company's fluoxetine portfolio across capsules and tablets in 10 mg, 20 mg, and 60 mg strengths, with a combined market size of ~US$ 130 million. The new product enhances dosing flexibility and will be manufactured in Puducherry. Fluoxetine is an SSRI used for treating MDD, OCD, bulimia nervosa, and panic disorder.

Strides Pharma gains approval for Fluoxetine Tabs 60 mg, completing its portfolio of the drug in 10 mg, 20 mg, and 60 mg ranges across capsules and tablets. The combined market size for these is $130 million. The company plans to launch all strengths soon, enhancing dosing flexibility. Strides Pharma aims to file two niche products with the FDA by Q1 next year, each with a potential market size of $600–700 million.

Strides Pharma shares surged to an all-time high of ₹1,395 after its subsidiary received USFDA approval for a generic Theophylline extended-release tablet, enhancing its U.S. market presence.

Strides Pharma share price hit an all-time high after its Singapore subsidiary received USFDA approval for generic Theophylline extended-release tablets, to be manufactured in Bangalore.